Comparison of ventricular tachyarrhythmia characteristics in patients with idiopathic dilated or ischemic cardiomyopathy and defibrillators implanted for primary prevention

Clinical Cardiology

Volumn 34, Issue 10, 2011, Pages 604-609

  Streitner, Florian ^a   Kuschyk, Juergen ^a   Dietrich, Claudia ^a   Mahl, Eva ^a   Streitner, Ines ^a   Doesch, Christina ^a   Veltmann, Christian ^a   Schimpf, Rainer ^a   Wolpert, Christian ^b   Borggrefe, Martin ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b KLINIKUM LUDWIGSBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; COMPARATIVE STUDY; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; DEFIBRILLATOR; FEMALE; FOLLOW UP; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART VENTRICLE TACHYCARDIA; HUMAN; ISCHEMIC CARDIOMYOPATHY; MAJOR CLINICAL STUDY; MALE;

AGED; CARDIOMYOPATHIES; CARDIOMYOPATHY, DILATED; CHI-SQUARE DISTRIBUTION; DEATH, SUDDEN, CARDIAC; DEFIBRILLATORS, IMPLANTABLE; ELECTRIC COUNTERSHOCK; FEMALE; GERMANY; HEART FAILURE; HUMANS; KAPLAN-MEIER ESTIMATE; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; PATIENT SELECTION; PRACTICE GUIDELINES AS TOPIC; PRIMARY PREVENTION; PROSPECTIVE STUDIES; STROKE VOLUME; TACHYCARDIA, VENTRICULAR; TREATMENT OUTCOME; VENTRICULAR FIBRILLATION; VENTRICULAR FUNCTION, LEFT;

EID: 80054097970     PISSN: 01609289     EISSN: 19328737     Source Type: Journal    
DOI: 10.1002/clc.20949     Document Type: Article

References (25)

1. Priori SG, Aliot E, Blomstrom-Lundqvist C, et al. Task Force on Sudden Cardiac Death of the European Society of Cardiology. Eur Heart J. 2001; 22: 1374-1450. (Pubitemid 32771346)
2. Zipes DP, Wellens HJ., Sudden cardiac death. Circulation. 1998; 98: 2334-2351. (Pubitemid 28533855)
3. Spooner PM, Albert C, Benjamin EJ, et al. Sudden cardiac death, genes, and arrhythmogenesis: consideration of new population and mechanistic approaches from a national heart, lung, and blood institute workshop, part I. Circulation. 2001; 103: 2361-2364. (Pubitemid 32448800)
4. Sukhija R, Mehta V, Leonardi M, et al. Implantable cardioverter defibrillators for prevention of sudden cardiac death. Clin Cardiol. 2007; 30: 3-8. (Pubitemid 46147603)
5. Moss AJ, Hall WJ, Cannom DS, et al. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators. N Engl J Med. 1996; 335: 1933-1940. (Pubitemid 26428217)
6. Moss AJ, Zareba W, Hall WJ, et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med. 2002; 346: 877-883. (Pubitemid 34984635)
7. Dickstein K, Cohen-Solal A, Filippatos G, et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur Heart J. 2008; 29: 2388-2442.
8. Dec GW, Fuster V., Idiopathic dilated cardiomyopathy. N Engl J Med. 1994; 331: 1564-1575. (Pubitemid 24366905)
9. Zipes DP, Camm AJ, Borggrefe M, et al. ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac deathâexecutive summary: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death) Developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Eur Heart J. 2006; 27: 2099-2140.
10. Cevik C, Nugent K, Perez-Verdia A, et al. Prophylactic implantation of cardioverter defibrillators in idiopathic nonischemic cardiomyopathy for the primary prevention of death: a narrative review. Clin Cardiol. 2010; 33: 254-260.
11. Moss AJ., MADIT-I and MADIT-II. J Cardiovasc Electrophysiol. 2003; 14 (9 suppl): S96-S98. (Pubitemid 37115147)
12. Exner DV, Pinski SL, Wyse DG, et al. Electrical storm presages nonsudden death: the antiarrhythmics versus implantable defibrillators (AVID) trial. Circulation. 2001; 103: 2066-2071. (Pubitemid 32373009)
13. Hohnloser SH, Al-Khalidi HR, Pratt CM, et al. Electrical storm in patients with an implantable defibrillator: incidence, features, and preventive therapy: insights from a randomized trial. Eur Heart J. 2006; 27: 3027-3032. (Pubitemid 44950447)
14. Bansch D, Bocker D, Brunn J, et al. Clusters of ventricular tachycardias signify impaired survival in patients with idiopathic dilated cardiomyopathy and implantable cardioverter defibrillators. J Am Coll Cardiol. 2000; 36: 566-573. (Pubitemid 30624021)
15. Fazio G, Veltri EP, Tomaselli G, et al. Long-term follow-up of patients with nonischemic dilated cardiomyopathy and ventricular tachyarrhythmias treated with implantable cardioverter defibrillators. Pacing Clin Electrophysiol. 1991; 14 (11 pt 2): 1905-1910.
16. Grimm W, Hoffmann JJ, Muller HH, et al. Implantable defibrillator event rates in patients with idiopathic dilated cardiomyopathy, nonsustained ventricular tachycardia on Holter and a left ventricular ejection fraction below 30%. J Am Coll Cardiol. 2002; 39: 780-787. (Pubitemid 34185323)
17. Grimm W, Marchlinski FE., Shock occurrence and survival in 49 patients with idiopathic dilated cardiomyopathy and an implantable cardioverter- defibrillator. Eur Heart J. 1995; 16: 218-222.
18. Rankovic V, Karha J, Passman R, et al. Predictors of appropriate implantable cardioverter-defibrillator therapy in patients with idiopathic dilated cardiomyopathy. Am J Cardiol. 2002; 89: 1072-1076. (Pubitemid 34462853)
19. Kadish A, Dyer A, Daubert JP, et al. Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy. N Engl J Med. 2004; 350: 2151-2158. (Pubitemid 38637995)
20. Bardy GH, Lee KL, Mark DB, et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med. 2005; 352: 225-237. (Pubitemid 40110811)
21. Packer DL, Prutkin JM, Hellkamp AS, et al. Impact of implantable cardioverter-defibrillator, amiodarone, and placebo on the mode of death in stable patients with heart failure: analysis from the sudden cardiac death in heart failure trial. Circulation. 2009; 120: 2170-2176.
22. Kreuz J, Balta O, Liliegren N, et al. Incidence and characteristics of appropriate and inappropriate therapies in recipients of ICD implanted for primary prevention of sudden cardiac death. Pacing Clin Electrophysiol. 2007; 30 (suppl 1): S125-S127. (Pubitemid 46121825)
23. Verma A, Kilicaslan F, Marrouche NF, et al. Prevalence, predictors, and mortality significance of the causative arrhythmia in patients with electrical storm. J Cardiovasc Electrophysiol. 2004; 15: 1265-1270. (Pubitemid 39612632)
24. Attin M, Ideker RE, Pogwizd SM., Mechanistic insights into ventricular arrhythmias from mapping studies in humans. Heart Rhythm. 2008; 5 (6 suppl): S53-S58.
25. Tung R, Zimetbaum P, Josephson ME., A critical appraisal of implantable cardioverter-defibrillator therapy for the prevention of sudden cardiac death. J Am Coll Cardiol. 2008; 52: 1111-1121.